Clinical Trial: A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants

U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254728) titled 'A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants' on Nov. 19.

Brief Summary: The primary objective of this study is to evaluate the safety and tolerability of an oral bivalent GI.1/GII.4 norovirus vaccine administration in healthy lactating female participants and to assess the short-term immunogenicity of oral bivalent GI.1/GII.4 norovirus vaccine administration in healthy lactating female participants and its association with the immunogenicity response in breastmilk.

Study Start Date: Oct. 27, 2023

Study Type: INTERVENTIONAL

Condition: Norovirus Inf...